2013 Texas-Mexico Immunization Comparison Tool

The purpose of this tool is to be used as a reference for the 2013 immunization schedules of Texas and Mexico, facilitating the interpretation of Mexico’s National Vaccination Card and Texas’s Vaccination Scheme. It is aimed to health care providers on both sides of the Mexico-.‐Texas border.

It is a tool to guide health care providers in the care of children and adolescents that initiate a vaccination schedule in one side of the border and continue it on the other side.

NOTES: At present there are:

  1. Two licensed rotavirus vaccines in the US: Rotarix® (2 doses) and RotaTeq® (3 doses) to complete the series.
  2. Three licensed monovalent Hib vaccines in the US: ActHIB® (4 doses), PedvaxHIB® (3 doses) and Hiberix® (only licensed for the 4th dose to complete the series).
  3. Six licensed combination vaccines in the US: Pediarix® (DTaP-IPV-HepB), Pentacel® (DTaP-IPV-Hib), COMVAX® (HepB-Hib), Kinrix™ (DTaP-IPV), MenHibrix® (Hib-MenCY)  and ProQuad® (MMRV).
  4. Influenza vaccines in the US: Inactive influenza vacine (IIV); and live, attenuated influenza vaccine (LAIV). (Minimum age: 6 months for IIV and 2 years for LAIV).
  5. Three licensed meningococcal conjugate vaccines (MCV) in the US: MenHibrix®, Mencatra®, and Menveo®. (Minimum age 6 weeks for MenHibrix® (Hib-MenCY), 9 months for Menactra® [MCV4-D], 2 years for Menveo® [MCV4-CRM]).

It is important to consider that there are different abbreviations / names for the same vaccine in the same country and in both countries (ex. Hep B = HBV, HpB, HepB) and that there are similar vaccines produced by different laboratories and sometimes have different recommended application schedules.


icon 2013 Texas – Mexico Immunization Comparison Tool

It is not a guide to compare the biological agents used in the Immunizations, nor an immunological study. This tool was developed by Pan American Health Organization/World Health Organization, and revised by the Texas Department of State Health Services, Immunization Branch, Region II Immunization Program; Centers for Disease Control and Prevention; Tamaulipas and Chihuahua’s State Secretaries of Health Immunization Programs.

  1. Persons 7 through 10 years who are not fully immunized should receive a single dose of Tdap and any adult who have not previously received Tdap or for whom the vaccine status is unknown. This dose can be administered regardless of the interval since the last tetanus and diphtheria toxoid - containing vaccine
  2. Administer meningococcal conjugate vaccine (MCV4) at age 11 through 12 years with a booster at age 16 years.  If the first dose is administered at 13-15 years, a booster should be administered at 16-18 years.  If the first dose is administered at age 16 or older years, a booster dose is not needed.
  3. There are two licensed Human papillomavirus (HPV) vaccines in the US:  Quadrivalent (HPV4 [Gardasil®] and bivalent (HPV2 [Cervarix®]).  Either HPV4 or HPV2 is recommended in a 3-dose series for females.  HPV4 is recommended in a 3-dose series for males.  The vaccines series can be started beginning at age 9 years.
  4. Influenza vaccines in the US: Inactive influenza vacine (IIV); and live, attenuated influenza vaccine (LAIV). (Maximum age for LAIV: 49 years)